Key Insights Given the large stake in the stock by institutions, Immunic's stock price might be vulnerable to their... Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical ...

Novo Nordisk's Wegovy label update receives a positive opinion from the EMA's CHMP, highlighting improvements in heart ...

Investorideas.com, a go-to investing platform covering cannabis stocks releases an industry snapshot looking at the battle ...

Sana Biotechnology Inc (SANA) stock saw a modest uptick, ending the day at $4.62 which represents a slight increase of $0.33 or 7.69% from the prior close of $4.29. The stock opened at $4.47 and ...

Shares of Summit Therapeutics, whose cancer drug candidate turned heads after it outperformed a blockbuster drug from Merck, ...

Moderna 's ( MRNA -2.63%) stock fell by 13% on Sept. 12 upon the announcement of extensive cost cuts that would affect a ...

Healthcare ETFs hold the potential for higher returns, diversification, and exposure to stably growing companies. Therefore, ...

Biotech investing is a high-stakes game that may not suit the faint-hearted due to its inherent volatility. However, this sector can ...

ASX health stocks have fallen this week but Morgans analyst Scott Power is more optimistic after the Fed cut the cash rate by ...

The U.S. dollar weakened early Friday. A general mood of "risk on" is widely acknowledged as a "gently softer USD adds to the allure of risk assets," said Vishnu Varathan, head of Macro Research for ...

The end of the trading week likely can't come fast enough for Vanda Pharmaceuticals (NASDAQ: VNDA). The commercial-stage ...

Vir Biotechnology Inc (VIR) stock saw a decline, ending the day at $7.8 which represents a decrease of $-0.13 or -1.64% from the prior close of $7.93. The stock opened at $7.94 and touched a low of $7 ...